Precision Diagnostics Integrity Laboratories focuses on high complexity, rapid molecular diagnostics to improve patient outcomes and lower healthcare costs, presenting a sales opportunity to hospitals and payers seeking advanced testing capabilities and cost efficiency.

saliva testing Recent expansion includes Proliva DX tests using oral saliva specimens to enhance patient comfort and reduce invasive sampling, offering potential upsell to clinics aiming for patient-friendly testing workflows and increased compliance.

quantitative COVID The company made a notable move as the first US commercial provider to offer a quantitative COVID-19 test, signaling capabilities in advanced analytics and potential collaborations with health systems prioritizing precision viral load data for treatment decisions.

Innovator Award Recognition for innovation and integrity positions Integrity Laboratories as a credible partner for labs and healthcare organizations seeking cutting-edge, transparent clinical testing solutions.

Intercept Platform Launch of the Intercept PCR platform and diverse pathogen testing demonstrates a robust technology stack and breadth of capabilities, presenting opportunities to cross-sell comprehensive panels to reference laboratories and integrated delivery networks.